Skip to main content

Day: June 14, 2023

National Geospatial Intelligence Agency Selects Recent NV5 Acquisition Axim Geospatial for Geospatial Contract Valued Up to $900 Million

HOLLYWOOD, Fla., June 14, 2023 (GLOBE NEWSWIRE) — NV5 Global, Inc. (the “Company” or “NV5”) (Nasdaq: NVEE), announced today that its newly acquired subsidiary, Axim Geospatial, LLC (“Axim”), was awarded a prime contract with the National Geospatial-Intelligence Agency (NGA) under the GEOINT Enterprise Operations Service and Solutions Program with Industry, Core Mission Operations (GEO-SPI B). GEO-SPI B is a seven-year, multi-award contract vehicle valued up to $900 million and focused on delivering trusted geospatial intelligence (GEOINT) to NGA’s Analysis and Source Directorates. The GEO-SPI B award is Axim Geospatial’s largest contract win to date. GEO-SPI B is the follow-on contract to NGA’s Multi-Intelligence Analytics and Collection Support Services (MACSS) contract, the largest geospatial staff augmentation program...

Continue reading

Ferrellgas Partners, L.P. Reports Third Quarter Fiscal 2023 Results

Financial HighlightsGross Profit for the third fiscal quarter increased $10.4 million, or 4%, compared to the prior year period. Margin per gallon for the third fiscal quarter increased $0.13, or 12%, compared to the prior year period. Net earnings attributable to Ferrellgas Partners, L.P. increased $4.8 million, or 7%, compared to the prior year period. Adjusted EBITDA increased by $8.5 million, or 7%, compared to the prior year period.Company HighlightsFerrellgas was named as one of the “Most Trustworthy Companies in America” by Newsweek magazine. The Company welcomed Apollo Propane, Inc. located in Moraine, Ohio, as its newest acquisition to the Ferrellgas Family during the third fiscal quarter. 198 employees received Ferrellgas Flame Awards in the areas of Safety, Customer Service, Innovation, and Leadership. Additionally,...

Continue reading

Aleafia Health Announces Fourth Quarter and Annual Financial Results

Revenue increased 9% to $11.7 million for the period ended March 31, 2023 (“Q4 FY2023”) versus $10.7 million for the period ended March 31, 2022 Net revenue increased 33% to $9.4 million for Q4 FY2023 versus $7.0 million for the period ended March 31, 2022 Revenue increased 24% to $57.4 million for the 12 months ended March 31, 2023 (“FY2023”) over the twelve months ended March 31, 2022 Net revenue increased 19% to $42.8 million for FY2023 over the twelve months ended March 31, 2022 #5 and #2 market share ranking in Divvy pre-roll and milled product formats in Q4 FY2023 in Ontario1 318% growth in international net revenue2 in FY2023 over the twelve months ended March 31, 2022 Third consecutive quarter of positive Adjusted EBITDA3 achieved in Q4 FY2023TORONTO, June 14, 2023 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQB:...

Continue reading

Hot Sauce Market to Reach USD 5.09 Billion by 2030 | At a CAGR of 7.42%

Key companies covered in hot sauce market are The Kraft Heinz Company (U.S.) McCormick & Company, Inc. (U.S.) Campbell Soup Company (U.S.) Unilever PLC (U.K.) Conagra Brands Inc. (U.S.) McIlhenny Company (U.S.) Southeastern Mills, Inc. (U.S.) Hormel Foods Corporation (U.S.) Baumer Foods, Inc. (U.S.) T.W. Garner Food Company (U.S.) and more players profiled. Pune, India, June 14, 2023 (GLOBE NEWSWIRE) — The global hot sauce market size was USD 2.89 billion in 2022 and is projected to grow from USD 3.09 billion in 2023 to USD 5.09 billion by 2030, exhibiting a CAGR of 7.42% during the forecast period. The primary force behind the rise in globalization is the need for sauces, spices, and condiments. Due to their distinctive umami qualities, savory foods are becoming incredibly popular among customers all over the world. An increasingly...

Continue reading

Space Launch Services Market to Worth USD 20.54 Billion by 2030 | Fortune Business Insights™

The global Space Launch Services Market covered major segments By Orbit Type (LEO, MEO, GEO, and Others), By Launch Vehicle (Small Lift Launch Vehicle, Medium Lift Launch Vehicle, and Heavy Lift Launch Vehicle), By Payload (Satellite, Cargo, Human Spacecraft, and Testing Probes), and Region. Pune, India, June 14, 2023 (GLOBE NEWSWIRE) — The global space launch services market size was valued at USD 8.07 billion in 2022 and is expected to reach USD 9.15 billion in 2023 and is projected to touch USD 20.54 billion by 2030, recording a CAGR of 12.2% during the forecast period of 2023-2030. Space launch services help launch cargo, satellites, humans, and other payloads into the earth’s orbit or in deep space to conduct exploration activities. The market has many public and private companies that provide these services at varying costs....

Continue reading

POET Technologies Announces Sample Availability of “POET Infinity” and Testing with Two Lead Customers

Alpha samples of the chiplet-based transmitter platform for 400G, 800G and 1.6T data center solutions are ready for shipment TORONTO, June 14, 2023 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (TSXV: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer™ and Photonic Integrated Circuits (PICs) for the data center, telecommunication and artificial intelligence markets, today announced alpha sample readiness of “POET Infinity™”, a chiplet-based transmitter platform for 400G, 800G and 1.6T pluggable transceivers and co-packaged optics solutions. Two lead customers have agreed to partner with POET to test the alpha version of the Infinity chiplet. The POET Infinity chiplet complements the POET 800G 2xFR4 Receiver optical engine that the Company announced in February 2023,...

Continue reading

Ventyx Biosciences Announces Initiation of Dosing in a Phase 1 Trial of VTX3232, a Novel CNS-Penetrant NLRP3 Inhibitor

Topline data from the Phase 1 SAD/MAD trial of VTX3232 are expected in H1 2024 ENCINITAS, Calif., June 14, 2023 (GLOBE NEWSWIRE) — Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that the first subject has been dosed in a Phase 1 trial of VTX3232, a novel central nervous system (CNS)-penetrant NLRP3 inhibitor. “VTX3232 is our fourth internally discovered compound to enter the clinic and an exciting addition to our broad, wholly-owned clinical-stage pipeline of orally-delivered small molecules targeting large disease populations with high unmet need,” said Raju Mohan, Chief Executive Officer. “We believe we are well positioned to explore...

Continue reading

GXO Receives SDCE’s 2023 Top Supply Chain Projects Award for State-of-the-Art Automated Returns Operation in the U.S.

Award highlights successful effort to develop and deploy innovative, state-of-the-art automation for an industry-leading consumer electronics company GREENWICH, Conn., June 14, 2023 (GLOBE NEWSWIRE) — GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, announced today that it has been recognized by Supply & Demand Chain Executive magazine (SDCE) for the second consecutive year for a Top Supply Chain Project. The 2023 award turns the spotlight on a project to develop and deploy innovative, state-of-the-art returns automation for a Fortune 100 telecommunications company. “We’re pleased to be recognized by SDCE for what is one of the most innovative automation solutions for complex, high-value reverse logistics operating in the U.S.,” said Eduardo Pelleissone, President, Americas and Asia...

Continue reading

Nurix Therapeutics Presents Data from Studies of Its Targeted Protein Degraders in B Cell Malignancies and Initiates Expansion of NX-2127 Phase 1b Trial in Diffuse Large B Cell Lymphoma and Mantle Cell Lymphoma Indications

Initiation of NX-2127 Phase 1b expansion cohort in patients with diffuse large B cell lymphoma (DLBCL) was informed by a rapid and sustained complete response; Phase 1b expansion cohort also initiated in patients with mantle cell lymphoma (MCL) Clinical biomarker data from Phase 1a trial of NX-5948 demonstrate rapid, robust, and sustained degradation of Bruton’s tyrosine kinase (BTK) and support ongoing investigation of B cell malignancies NX-5948 crosses the blood brain barrier and catalyzes robust and efficient degradation of BTK, improving survival in an intracranial patient-cell-derived preclinical model of central nervous system (CNS) lymphoma SAN FRANCISCO, June 14, 2023 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein modulation drugs designed...

Continue reading

ArcelorMittal and John Cockerill announce plans to develop world’s first industrial scale low temperature, iron electrolysis plant

Volteron™ plant targeted to start-up in 2027 14 June 2023, 13:00 CET ArcelorMittal, the world’s leading steel company, and John Cockerill, a group leading the development of steel processing facilities and electrolysers, today announce plans to construct the world’s first industrial-scale low temperature, iron electrolysis plant. The Volteron™ plant, which in a first phase will produce between 40,000 and 80,000 tonnes a year of iron plates, is targeted to start production in 2027. Once the technology has been proven at this scale, the intention is to increase the plant’s annual capacity to between 300,000 and 1 million tonnes. ArcelorMittal and John Cockerill have been working together on an innovative electrochemical process to transform iron oxide into iron plates for the last few years. The successfully completed project,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.